| Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2 M Dittmar, JS Lee, K Whig, E Segrist, M Li, B Kamalia, L Castellana, ... Cell reports 35 (1), 2021 | 185 | 2021 |
| Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2 M Dittmar, JS Lee, K Whig, E Segrist, M Li, K Jurado, K Samby, H Ramage, ... biorxiv, 2020.06. 19.161042, 2020 | 59 | 2020 |
| Using diverse model systems to define intestinal epithelial defenses to enteric viral infections E Segrist, S Cherry Cell host & microbe 27 (3), 329-344, 2020 | 31 | 2020 |
| Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. Cell Rep 35: 108959 M Dittmar, JS Lee, K Whig, E Segrist, M Li, B Kamalia, L Castellana, ... | 19 | 2021 |
| Sirtuin Inhibitors Are Broadly Antiviral against Arboviruses BA Hackett, M Dittmar, E Segrist, N Pittenger, J To, T Griesman, ... mBio 10, e01446-19, 2019 | 19 | 2019 |
| Orally acquired cyclic dinucleotides drive dSTING-dependent antiviral immunity in enterocytes E Segrist, M Dittmar, B Gold, S Cherry Cell reports 37 (13), 2021 | 16 | 2021 |
| Drug repurposing screens reveal cell-typespecific entry pathways and FDA-approved drugs active against SARS-Cov-2. Cell Rep. 2021; 35 (1): 108959 M Dittmar, JS Lee, K Whig, E Segrist, M Li, B Kamalia J. CELREP, 2021 | 6 | 2021 |
| Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2. bioRxiv. 2020 M Dittmar, JS Lee, K Whig, E Segrist, M Li, K Jurado, K Samby, H Ramage, ... Google Scholar, 0 | 5 | |
| Tissue specific innate immune responses impact viral infection in Drosophila E Segrist, S Miller, B Gold, Y Li, S Cherry PLoS pathogens 20 (11), e1012672, 2024 | | 2024 |
| Adaptive immunity to retroelements promotes barrier integrity AC Wells, DS Lima-Junior, VM Link, M Smelkinson, SR Krishnamurthy, ... bioRxiv, 2024 | | 2024 |
| Uncovering the role of the local environment in shaping antiviral immunity of the female reproductive tract E Segrist, Y Belkaid The Journal of Immunology 210 (1_Supplement), 69.01-69.01, 2023 | | 2023 |
| Gutcha: The microbiota drives tumor-induced mortality E Segrist, S Cherry Immunity 55 (9), 1581-1583, 2022 | | 2022 |
| Tissue Specific Immunity: A Study of Antiviral Defenses and the Influence of the Microbiota E Segrist University of Pennsylvania, 2021 | | 2021 |
| Synthesis of novel heterocyclic chromone analog libraries and evaluation of their biological activity A Delawder, E Segrist, Y Wang ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016 | | 2016 |
| Synthesis and cytotoxic evaluation of ethyl amino and heteroaromatic ether analogues of naphthoquinone K Liles, A Delawder, E Segrist, M Manpadi ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016 | | 2016 |
| Investigation of the biological activity and mechanism of action of novel heterocyclic imines E Segrist, A Delawder, K Liles, D Dopp, M Manpadi ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016 | | 2016 |
